Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Austar Lifesciences Ltd. ( (HK:6118) ) has shared an announcement.
Austar Lifesciences Ltd. has announced its upcoming annual general meeting scheduled for May 23, 2025, in Shanghai, China. The meeting will address several key business items, including the adoption of the 2024 financial statements, re-election of directors, and re-appointment of the company’s auditor. Additionally, resolutions will be considered to authorize the board to manage the issuance and allotment of shares, reflecting the company’s strategic focus on maintaining governance and operational flexibility.
More about Austar Lifesciences Ltd.
Austar Lifesciences Ltd. is a company incorporated in the Cayman Islands, operating in the life sciences industry. It focuses on providing products and services related to the pharmaceutical and biotechnology sectors, aiming to support the development and manufacturing processes within these fields.
YTD Price Performance: 40.35%
Average Trading Volume: 142,576
Technical Sentiment Signal: Buy
Current Market Cap: HK$430.6M
For detailed information about 6118 stock, go to TipRanks’ Stock Analysis page.